Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
15.00
-0.29 (-1.90%)
At close: Jul 8, 2025, 4:00 PM
15.39
+0.39 (2.60%)
After-hours: Jul 8, 2025, 7:25 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $225.65 million as of July 8, 2025.
Market Cap
225.65M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$15.00
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $111.34M to $225.65M, an increase of 102.67%. That is a compound annual growth rate of 12,296,129.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2025 | 225.65M | -1.31% |
| Jul 7, 2025 | 228.64M | -3.78% |
| Jul 3, 2025 | 237.61M | 2.22% |
| Jul 2, 2025 | 232.46M | -3.75% |
| Jul 1, 2025 | 241.50M | 0.06% |
| Jun 30, 2025 | 241.35M | 1.51% |
| Jun 27, 2025 | 237.76M | -5.92% |
| Jun 26, 2025 | 252.72M | -6.11% |
| Jun 25, 2025 | 269.17M | 19.48% |
| Jun 24, 2025 | 225.28M | -1.54% |
| Jun 23, 2025 | 228.79M | 2.00% |
| Jun 20, 2025 | 224.31M | 2.60% |
| Jun 18, 2025 | 218.62M | 10.17% |
| Jun 17, 2025 | 198.44M | 78.22% |
| Jun 16, 2025 | 111.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.83B |
| Johnson & Johnson | 373.59B |
| AbbVie | 331.43B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 275.51B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 232.62B |
| AstraZeneca | 216.19B |